iBio Inc

ASE:IBIO   11:00:19 AM EDT
-0.11 (-33.51%)
Other Pre-Announcement, Mergers / Acquisitions

Ibio Acquires Rubryc Therapeutics AI Drug Discovery Platform And Pipeline

Published: 09/21/2022 13:05 GMT
iBio Inc (IBIO) - Ibio Acquires Rubryc Therapeutics’ Ai Drug Discovery Platform and Pipeline.
Ibio Inc - Purchase Terms Include Upfront Payment of $1 Million in Ibio's Common Stock to Rubryc Investors.
Ibio - Initiated Review of Opportunities to Accelerate Transformation While Extending Cash Runway Beyond Previous Guidance of September 30, 2023.